Internal Reference Number: FOI_8557
Date Request Received: 04/04/2025 00:00:00
Date Request Replied To: 30/04/2025 00:00:00
This response was sent via: By Email
Request Summary: Atopic Dermatitis
Request Category: Researcher
| Question Number 1: How many patients were treated in the last 4 months (December 2024 to March 2025) by the dermatology department with each of the following products: • Abrocitinib • Acitretin • Alitretinoin • Azathioprine • Baricitinib • Ciclosporin • Dupilumab • Lebrikizumab • Methotrexate • Mycophenolate mofetil • Pimecrolimus • Phototherapy (UVB or PUVA) - for Atopic Dermatitis only • Tacrolimus ointment • Tralokinumab • Upadacitinib • Nemolizumab | |
| Answer To Question 1: • Abrocitinib <5 • Acitretin 32 • Alitretinoin <5 • Azathioprine <5 • Baricitinib 0 • Ciclosporin 11 • Dupilumab 29 • Lebrikizumab <5 • Methotrexate 36 • Mycophenolate mofetil <5 • Pimecrolimus 23 • Phototherapy (UVB or PUVA) - for Atopic Dermatitis only 12 • Tacrolimus ointment 50 • Tralokinumab <5 • Upadacitinib <5 • Nemolizumab 0 | |
| Question Number 2: . Of the patients treated in the last 4 months with any of the products listed in question 1, please provide the number of patients by the following age group: • 6 months to 5 • Age 6-11 • Age 12-17 • Age 18 and above | |
| Answer To Question 2: Phototherapy (UVB or PUVA) - for Atopic Dermatitis only: • 6 months to 5 - 0 • Age 6-11 - 0 • Age 12-17 - <5 • Age 18 and above - 11 We have made the assumption that the only medications being used in patients under 18 years of age are the topical products tacrolimus and pimecrolimus: Age 6 months to 5 years - <5 Age 6-11 - <5 Age 12-17 - <5 Age 18 and above - 68 All other medications would have been for patients age 18 and above. | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
